x

Search for a clinical trial

* (*) mandatory field

17 Result(s)

Recruiting trial = Recruiting trial
; Ongoing trial = Ongoing trial
; Funded by an IRDiRC member =

National clinical trial(s)

FRANCE

BRETAGNE
BREST

Thalidomide treatment for agnogenic myeloid metaplasia (Phase II) - Terminated -
CHU de Brest - Hôpital de la Cavale Blanche
Laboratoire d'hématologie

ITALY

PIEMONTE
TORINO

A Phase II Multicenter Study of Melphalan, Prednisone, Thalidomide and Defibrotide in Advanced and refractory Multiple Myeloma Patients - IT
A.O.U. Città della Salute e della Scienza di Torino - Ospedale Molinette
S.C. di Ematologia

NETHERLANDS

Utrecht
UTRECHT

Combination Chemotherapy With or Without Thalidomide in Treating Patients With Multiple Myeloma
UMC Utrecht - Universitair Medisch Centrum Utrecht
Afdeling Hematologie

UNITED KINGDOM

Devon
EXETER

Ongoing trial
AITL: Phase II Trial of fludarabine and cyclophosphamide followed by Thalidomide for angioimmunoblastic lymphoma
Royal Devon and Exeter Hospital - Wonford site
Department of Haematology

UNITED KINGDOM

Greater Manchester
ADDRESS: NOT PROVIDED - UK

The effect of Thalidomide on sputum biomarkers in IPF cough
Institution: Information not provided - UK